Toggle menu
  • Login or Sign Up
  • 0
  • Wishlist
    • USD
      • British Pound
      • US Dollar
  • Biopharma Research
    Reset Search ×
    • 0
    Reset Search ×
    • USD
      • British Pound
      • US Dollar

      Main Menu

    • OUR SERVICES
      • Custom Research Services
      • Laboratory End User Surveys
    • ABOUT US
    • CONTACT US
    • Shop By Category

    • All Diagnostics Markets
    • PARTNERING, LICENSING, M&A
    • Multiplex Diagnostics
    • Therapeutics
    • Genomics
    • Cancer Diagnostics
    • Infectious Disease Diagnostics
    • COVID-19 Diagnostics
    • Point of Care (POC) Diagnostics
    • Direct-to-Consumer (DTC) Diagnostics
    • Rapid Diagnostics
    • Laboratory Techniques
    • Medical Laboratory Services
    • Calibration
    • USD
      • British Pound
      • US Dollar
    • Gift Certificates
    • Login or Sign Up

    Market ReportsMarket Reports

    Shop by Category

  • All Diagnostics Markets
  • PARTNERING, LICENSING, M&A
  • Multiplex Diagnostics
  • Therapeutics
  • Genomics
  • Cancer Diagnostics
  • Infectious Disease Diagnostics
  • COVID-19 Diagnostics
  • Point of Care (POC) Diagnostics
  • Direct-to-Consumer (DTC) Diagnostics
  • Rapid Diagnostics
  • Laboratory Techniques
  • Medical Laboratory Services
  • Calibration

    • Main Menu

    • OUR SERVICES
      • Custom Research Services
      • Laboratory End User Surveys
    • ABOUT US
    • CONTACT US
    • Shop By Category

    • All Diagnostics Markets
    • PARTNERING, LICENSING, M&A
    • Multiplex Diagnostics
    • Therapeutics
    • Genomics
    • Cancer Diagnostics
    • Infectious Disease Diagnostics
    • COVID-19 Diagnostics
    • Point of Care (POC) Diagnostics
    • Direct-to-Consumer (DTC) Diagnostics
    • Rapid Diagnostics
    • Laboratory Techniques
    • Medical Laboratory Services
    • Calibration
    Reset Search ×
    • 0
    • Home
    • Cancer Diagnostics
    • Global Diagnostics Partnering Terms and Agreements 2016-2023
  • Global Diagnostics Partnering Terms and Agreements 2016 to 2023
  • Global Diagnostics Partnering Terms and Agreements 2016 to 2023
  • Global Diagnostics Partnering Terms and Agreements 2016 to 2023 Global Diagnostics Partnering Terms and Agreements 2016 to 2023

    Global Diagnostics Partnering Terms and Agreements 2016-2023

    $3,995.00
    (You save )
    Write a Review

    SKU:
    CP2104-SU
    Availability:
    Report will be sent the same business day after receipt of cleared payment

    Adding to cart… category.add_cart_announcement
    Save to Wishlist
    • Create New Wish List

    Share This Article

    • Overview

    Product Description

    Global Diagnostics Partnering Terms and Agreements 2016-2023

    • Publication date: May 2023
    • Page count: 1500+
    • Format: Interactive PDF and online
    • Edition no: 3

    Request a sample

    The Global Diagnostics Partnering Terms and Agreements 2016-2023 report provides comprehensive understanding and unprecedented access to the diagnostic partnering agreements entered into by leading companies in the life sciences.

    The report includes:

    • Comprehensive directory of diagnostics deals since 2016
    • Diagnostic contract documents
    • Diagnostic agreement terms
    • Diagnostic agreement structure
    • Top diagnostic deals by value
    • Most active diagnostic dealmakers

    The report provides users with the following key benefits:

    • In-depth understanding of diagnostics deal trends since 2016
    • Access to headline, upfront, milestone and royalty data
    • Detailed access to actual diagnostics contracts entered into by leading companies
    • Identify most active diagnostics dealmakers since 2016
    • Insight into terms included in a diagnostics partnering agreement, with real world examples
    • Understand the key deal terms companies have agreed in previous deals           
    • Undertake due diligence to assess suitability of your proposed deal terms for partner companies

     

    The report provides a detailed understanding and analysis of how and why companies enter diagnostics partnering deals. These deals tend to be multicomponent, starting with collaborative R&D, and proceed to commercialization of outcomes.

    The report takes the reader through a comprehensive review diagnostics deal trends, key players, top deal values, as well as deal financials, allowing the understanding of how, why and under what terms, companies are entering diagnostics partnering deals.

    The report presents financial deal term values for diagnostics deals, listing by headline value, upfront payments, milestone payments and royalties, enabling readers to analyse and benchmark the financial value of deals.

    The middle section of the report explores the leading dealmakers in the diagnostics partnering field; both the leading deal values and most active diagnostics dealmaker companies are reported allowing the reader to see who is succeeding in this dynamic dealmaking market.

    One of the key highlights of the report is that over 3,000 online deal records of actual diagnostics deals, as disclosed by the deal parties, are included towards the end of the report in a directory format – by company A-Z, stage of development, deal type, therapy focus, and technology type - that is easy to reference. Each deal record in the report links via weblink to an online version of the deal.

    In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners. Whilst many companies will be seeking details of the payment clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases and databases do not.

    The initial chapters of this report provide an orientation of diagnostics dealmaking. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of the trends in diagnostics dealmaking since 2016, including details of headline, upfront, milestone and royalty terms.

    Chapter 3 provides a review of the leading diagnostics deals since 2016. Deals are listed by headline value. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

    Chapter 4 provides a comprehensive listing of the top 25 most active companies in diagnostics dealmaking with a brief summary followed by a comprehensive listing of diagnostics deals announded by that company, as well as contract documents, where available.

    Chapter 5 provides a comprehensive and detailed review of diagnostics partnering deals signed and announced since Jan 2016, where a contract document is available in the public domain. Each deal title links via Weblink to an online version of the deal record and contract document, providing easy access to each contract document on demand.

    Chapter 6 provides a comprehensive and detailed review of diagnostics partnering deals signed and announced since Jan 2016. The chapter is organized by specific diagnostics technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each deal on demand.

    A comprehensive series of appendices is provided organized by diagnostics partnering company A-Z, stage of development, deal type, and therapy focus. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each deal on demand.

    The report also includes numerous tables and figures that illustrate the trends and activities in diagnostics partnering and dealmaking since 2016.

    In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of diagnostics technologies and products.

    Report scope

    Global Diagnostics Partnering Terms and Agreements 2016-2023 is intended to provide the reader with an in-depth understanding and access to diagnostics trends and structure of deals entered into by leading companies worldwide.

    Diagnostics Partnering Terms and Agreements includes:

     

    • Trends in diagnostics dealmaking since 2016
    • Access to headline, upfront, milestone and royalty data
    • Access to diagnostics contract documents
    • Leading diagnostics deals by value since 2016
    • Most active diagnostics dealmakers since 2016

     

    In Global Diagnostics Partnering Terms and Agreements 2016-2023, the available deals are listed by:

    • Company A-Z
    • Headline value
    • Stage of development at signing
    • Deal component type
    • Specific therapy target
    • Technology type

     

    Each deal title links via weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

    The Global Diagnostics Partnering Terms and Agreements 2016-2023 report provides comprehensive access to available deals and contract documents for over 3,000 diagnostics deals.

    Analyzing actual contract agreements allows assessment of the following:

    • What are the precise rights granted or optioned?
    • What is actually granted by the agreement to the partner company?
    • What exclusivity is granted?
    • What is the payment structure for the deal?
    • How are sales and payments audited?
    • What is the deal term?
    • How are the key terms of the agreement defined?
    • How are IPRs handled and owned?
    • Who is responsible for commercialization?
    • Who is responsible for development, supply, and manufacture?
    • How is confidentiality and publication managed?
    • How are disputes to be resolved?
    • Under what conditions can the deal be terminated?
    • What happens when there is a change of ownership?
    • What sublicensing and subcontracting provisions have been agreed?
    • Which boilerplate clauses does the company insist upon?
    • Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
    • Which jurisdiction does the company insist upon for agreement law?

    Product Videos

    Custom Field

    Product Reviews

    Write a Review

    Write a Review

    ×
    Global Diagnostics Partnering Terms and Agreements 2016 to 2023
    Global Diagnostics Partnering Terms and Agreements 2016-2023
    ×
    • Recommended
    • You May Also Like
    COVID-19 Diagnostics Markets 2023 to 2027
    Quick view

    COVID-19 Diagnostics: Global Market Forecasts by Technology, Product, Channel and Country - Market Size Outlook with Executive and Consultant Guides 2023 to 2027

    $6,995.00 - $13,995.00
    Choose Options
    Global Precision Medicine Partnering Terms and Agreements 2016 to 2023 - Deal Trends, Players and Financials Global Precision Medicine Partnering Terms and Agreements 2016 to 2023 - Deal Trends, Players and Financials
    Quick view

    Global Precision Medicine Partnering Terms and Agreements 2016-2023

    $3,995.00 - $17,995.00
    Choose Options
    Oncology Partnering 2015 to 2023: Deal Terms, Players and Financials Oncology Partnering 2015 to 2023: Deal Terms, Players and Financials
    Quick view

    Oncology Partnering 2015 to 2023: Deal Terms, Players and Financials

    $3,995.00 - $17,995.00
    Choose Options
    Global Infectious Disease Vaccines Partnering Terms and Agreements 2016 to 2023: Deal Trends, Players and Financials Global Infectious Disease Vaccines Partnering Terms and Agreements 2016 to 2023: Deal Trends, Players and Financials
    Quick view

    Global Infectious Disease Vaccine Partnering Terms and Agreements 2016-2023

    $3,995.00 - $17,995.00
    Choose Options
    Global Antibody Partnering Terms and Agreements 2016 to 2023 Global Antibody Partnering Terms and Agreements 2016 to 2023
    Quick view

    Global Antibody Partnering Terms and Agreements 2016-2023

    $3,995.00 - $17,995.00
    Choose Options
    Global Antibody Partnering Terms and Agreements 2016 to 2023 Global Antibody Partnering Terms and Agreements 2016 to 2023
    Quick view

    Global Antibody Partnering Terms and Agreements 2016-2023

    $3,995.00 - $17,995.00
    Choose Options
    Global Infectious Disease Vaccines Partnering Terms and Agreements 2016 to 2023: Deal Trends, Players and Financials Global Infectious Disease Vaccines Partnering Terms and Agreements 2016 to 2023: Deal Trends, Players and Financials
    Quick view

    Global Infectious Disease Vaccine Partnering Terms and Agreements 2016-2023

    $3,995.00 - $17,995.00
    Choose Options
    Global Precision Medicine Partnering Terms and Agreements 2016 to 2023 - Deal Trends, Players and Financials Global Precision Medicine Partnering Terms and Agreements 2016 to 2023 - Deal Trends, Players and Financials
    Quick view

    Global Precision Medicine Partnering Terms and Agreements 2016-2023

    $3,995.00 - $17,995.00
    Choose Options
    Oncology Partnering 2015 to 2023: Deal Terms, Players and Financials Oncology Partnering 2015 to 2023: Deal Terms, Players and Financials
    Quick view

    Oncology Partnering 2015 to 2023: Deal Terms, Players and Financials

    $3,995.00 - $17,995.00
    Choose Options
    Home Diagnostics Markets 2023 to 2027
    Quick view

    HOME DIAGNOSTICS MARKETS: Strategies and Trends, Forecasts by Application, Channel, Technology and Country with Market Analysis and Executive Guides 2023 to 2027

    $6,995.00 - $13,995.00
    Choose Options
    Latent TB Diagnostics Markets 2023 to 2027
    Quick view

    Latent TB Diagnostics: Global Market Analysis and Forecasts by Assay, Risk Factor and Lab/Place with Executive and Consultant Guides 2023 to 2027

    $6,995.00 - $13,995.00
    Choose Options
    Smart In Vitro Diagnostics Markets 2023 to 2027
    Quick view

    SMART IN VITRO DIAGNOSTICS: ARTIFICIAL INTELLIGENCE FOR IVD MARKETS BY APPLICATION, TECHNOLOGY AND USER WITH EXECUTIVE AND CONSULTANT GUIDES 2023-2027

    $6,995.00 - $13,995.00
    Choose Options
    Molecular Diagnostics Markets at the Point of Care 2023 to 2027
    Quick view

    Molecular Diagnostics at the Point of Care by Application, Technology, Place, Product and Country with Executive Guides 2023 to 2027

    $6,995.00 - $13,995.00
    Choose Options
    Current Agreements: Powerful Intelligence for Dealmakers Current Agreements: Powerful Intelligence for Dealmakers
    Quick view

    Current Agreements: Life Science Deal Tracker Database (12 month access)

    $5,995.00 - $24,995.00
    Choose Options
    Metagenomic Markets 2023 to 2027
    Quick view

    Metagenomic Markets: Global Market Analysis with Forecasts by Applications, Technologies, Product and User with Executive and Consultant Guides 2023 to 2027

    $6,995.00 - $13,995.00
    Choose Options
    • You May Also Like
    • Recommended
    • Global Antibody Partnering Terms and Agreements 2016 to 2023 Global Antibody Partnering Terms and Agreements 2016 to 2023
      Quick view

      Global Antibody Partnering Terms and Agreements 2016-2023

      $3,995.00 - $17,995.00
      Choose Options
    • Global Infectious Disease Vaccines Partnering Terms and Agreements 2016 to 2023: Deal Trends, Players and Financials Global Infectious Disease Vaccines Partnering Terms and Agreements 2016 to 2023: Deal Trends, Players and Financials
      Quick view

      Global Infectious Disease Vaccine Partnering Terms and Agreements 2016-2023

      $3,995.00 - $17,995.00
      Choose Options
    • Global Precision Medicine Partnering Terms and Agreements 2016 to 2023 - Deal Trends, Players and Financials Global Precision Medicine Partnering Terms and Agreements 2016 to 2023 - Deal Trends, Players and Financials
      Quick view

      Global Precision Medicine Partnering Terms and Agreements 2016-2023

      $3,995.00 - $17,995.00
      Choose Options
    • Oncology Partnering 2015 to 2023: Deal Terms, Players and Financials Oncology Partnering 2015 to 2023: Deal Terms, Players and Financials
      Quick view

      Oncology Partnering 2015 to 2023: Deal Terms, Players and Financials

      $3,995.00 - $17,995.00
      Choose Options
    • Home Diagnostics Markets 2023 to 2027
      Quick view

      HOME DIAGNOSTICS MARKETS: Strategies and Trends, Forecasts by Application, Channel, Technology and Country with Market Analysis and Executive Guides 2023 to 2027

      $6,995.00 - $13,995.00
      Choose Options
    • Latent TB Diagnostics Markets 2023 to 2027
      Quick view

      Latent TB Diagnostics: Global Market Analysis and Forecasts by Assay, Risk Factor and Lab/Place with Executive and Consultant Guides 2023 to 2027

      $6,995.00 - $13,995.00
      Choose Options
    • Smart In Vitro Diagnostics Markets 2023 to 2027
      Quick view

      SMART IN VITRO DIAGNOSTICS: ARTIFICIAL INTELLIGENCE FOR IVD MARKETS BY APPLICATION, TECHNOLOGY AND USER WITH EXECUTIVE AND CONSULTANT GUIDES 2023-2027

      $6,995.00 - $13,995.00
      Choose Options
    • Molecular Diagnostics Markets at the Point of Care 2023 to 2027
      Quick view

      Molecular Diagnostics at the Point of Care by Application, Technology, Place, Product and Country with Executive Guides 2023 to 2027

      $6,995.00 - $13,995.00
      Choose Options
    • Current Agreements: Powerful Intelligence for Dealmakers Current Agreements: Powerful Intelligence for Dealmakers
      Quick view

      Current Agreements: Life Science Deal Tracker Database (12 month access)

      $5,995.00 - $24,995.00
      Choose Options
    • Metagenomic Markets 2023 to 2027
      Quick view

      Metagenomic Markets: Global Market Analysis with Forecasts by Applications, Technologies, Product and User with Executive and Consultant Guides 2023 to 2027

      $6,995.00 - $13,995.00
      Choose Options
    • COVID-19 Diagnostics Markets 2023 to 2027
      Quick view

      COVID-19 Diagnostics: Global Market Forecasts by Technology, Product, Channel and Country - Market Size Outlook with Executive and Consultant Guides 2023 to 2027

      $6,995.00 - $13,995.00
      Choose Options
    • Global Precision Medicine Partnering Terms and Agreements 2016 to 2023 - Deal Trends, Players and Financials Global Precision Medicine Partnering Terms and Agreements 2016 to 2023 - Deal Trends, Players and Financials
      Quick view

      Global Precision Medicine Partnering Terms and Agreements 2016-2023

      $3,995.00 - $17,995.00
      Choose Options
    • Oncology Partnering 2015 to 2023: Deal Terms, Players and Financials Oncology Partnering 2015 to 2023: Deal Terms, Players and Financials
      Quick view

      Oncology Partnering 2015 to 2023: Deal Terms, Players and Financials

      $3,995.00 - $17,995.00
      Choose Options
    • Global Infectious Disease Vaccines Partnering Terms and Agreements 2016 to 2023: Deal Trends, Players and Financials Global Infectious Disease Vaccines Partnering Terms and Agreements 2016 to 2023: Deal Trends, Players and Financials
      Quick view

      Global Infectious Disease Vaccine Partnering Terms and Agreements 2016-2023

      $3,995.00 - $17,995.00
      Choose Options
    • Global Antibody Partnering Terms and Agreements 2016 to 2023 Global Antibody Partnering Terms and Agreements 2016 to 2023
      Quick view

      Global Antibody Partnering Terms and Agreements 2016-2023

      $3,995.00 - $17,995.00
      Choose Options
    ×
    Contact Us
    Westfield House
    Millfield Lane
    Nether Poppleton
    YORK, YO26 6GA
    United Kingdom
    +44(0)1904 868857
    Accounts & Orders
    • Wishlist
    • Login or Sign Up
    • Order Status
    • Privacy Security Shipping
    Navigate
    • OUR SERVICES
    • ABOUT US
    • CONTACT US
    Join Our Mailing List

    Sign up for our newsletter to receive specials and up to date product news and releases.

    • © Biopharma Research Ltd